Europe Recombinant Human Insulin Market Report 2017

Published Date : 2017-02-20

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 127

Notes:
Sales, means the sales volume of Recombinant Human Insulin
Revenue, means the sales value of Recombinant Human Insulin

This report studies sales (consumption) of Recombinant Human Insulin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Novo Nordisk
Eli Lilly
Bioton
Dongbao
United Laboratories (TUL)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Human Insulin in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Recombinant Human Insulin in each application, can be divided into
Application 1
Application 2

Table of Contents



Europe Recombinant Human Insulin Market Report 2017

1 Recombinant Human Insulin Overview

1.1 Product Overview and Scope of Recombinant Human Insulin

1.2 Classification of Recombinant Human Insulin

1.2.1 Type I

1.2.2 Type II

1.3 Application of Recombinant Human Insulin

1.3.1 Application 1

1.3.2 Application 2

1.4 Recombinant Human Insulin Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Recombinant Human Insulin (2012-2022)

1.5.1 Europe Recombinant Human Insulin Sales and Growth Rate (2012-2022)

1.5.2 Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2022)



2 Europe Recombinant Human Insulin by Manufacturers, Type and Application

2.1 Europe Recombinant Human Insulin Market Competition by Manufacturers

2.1.1 Europe Recombinant Human Insulin Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Recombinant Human Insulin Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Recombinant Human Insulin (Volume and Value) by Type

2.2.1 Europe Recombinant Human Insulin Sales and Market Share by Type (2012-2017)

2.2.2 Europe Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)

2.3 Europe Recombinant Human Insulin (Volume and Value) by Countries

2.3.1 Europe Recombinant Human Insulin Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Recombinant Human Insulin Revenue and Market Share by Countries (2012-2017)

2.4 Europe Recombinant Human Insulin (Volume) by Application



3 Germany Recombinant Human Insulin (Volume, Value and Sales Price)

3.1 Germany Recombinant Human Insulin Sales and Value (2012-2017)

3.1.1 Germany Recombinant Human Insulin Sales and Growth Rate (2012-2017)

3.1.2 Germany Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

3.1.3 Germany Recombinant Human Insulin Sales Price Trend (2012-2017)

3.2 Germany Recombinant Human Insulin Sales and Market Share by Manufacturers

3.3 Germany Recombinant Human Insulin Sales and Market Share by Type

3.4 Germany Recombinant Human Insulin Sales and Market Share by Application



4 France Recombinant Human Insulin (Volume, Value and Sales Price)

4.1 France Recombinant Human Insulin Sales and Value (2012-2017)

4.1.1 France Recombinant Human Insulin Sales and Growth Rate (2012-2017)

4.1.2 France Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

4.1.4 France Recombinant Human Insulin Sales Price Trend (2012-2017)

4.2 France Recombinant Human Insulin Sales and Market Share by Manufacturers

4.3 France Recombinant Human Insulin Sales and Market Share by Type

4.4 France Recombinant Human Insulin Sales and Market Share by Application



5 UK Recombinant Human Insulin (Volume, Value and Sales Price)

5.1 UK Recombinant Human Insulin Sales and Value (2012-2017)

5.1.1 UK Recombinant Human Insulin Sales and Growth Rate (2012-2017)

5.1.2 UK Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

5.1.5 UK Recombinant Human Insulin Sales Price Trend (2012-2017)

5.2 UK Recombinant Human Insulin Sales and Market Share by Manufacturers

5.3 UK Recombinant Human Insulin Sales and Market Share by Type

5.4 UK Recombinant Human Insulin Sales and Market Share by Application



6 Russia Recombinant Human Insulin (Volume, Value and Sales Price)

6.1 Russia Recombinant Human Insulin Sales and Value (2012-2017)

6.1.1 Russia Recombinant Human Insulin Sales and Growth Rate (2012-2017)

6.1.2 Russia Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

6.1.6 Russia Recombinant Human Insulin Sales Price Trend (2012-2017)

6.2 Russia Recombinant Human Insulin Sales and Market Share by Manufacturers

6.3 Russia Recombinant Human Insulin Sales and Market Share by Type

6.4 Russia Recombinant Human Insulin Sales and Market Share by Application



7 Italy Recombinant Human Insulin (Volume, Value and Sales Price)

7.1 Italy Recombinant Human Insulin Sales and Value (2012-2017)

7.1.1 Italy Recombinant Human Insulin Sales and Growth Rate (2012-2017)

7.1.2 Italy Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

7.1.7 Italy Recombinant Human Insulin Sales Price Trend (2012-2017)

7.2 Italy Recombinant Human Insulin Sales and Market Share by Manufacturers

7.3 Italy Recombinant Human Insulin Sales and Market Share by Type

7.4 Italy Recombinant Human Insulin Sales and Market Share by Application



8 Spain Recombinant Human Insulin (Volume, Value and Sales Price)

8.1 Spain Recombinant Human Insulin Sales and Value (2012-2017)

8.1.1 Spain Recombinant Human Insulin Sales and Growth Rate (2012-2017)

8.1.2 Spain Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

8.1.8 Spain Recombinant Human Insulin Sales Price Trend (2012-2017)

8.2 Spain Recombinant Human Insulin Sales and Market Share by Manufacturers

8.3 Spain Recombinant Human Insulin Sales and Market Share by Type

8.4 Spain Recombinant Human Insulin Sales and Market Share by Application



9 Benelux Recombinant Human Insulin (Volume, Value and Sales Price)

9.1 Benelux Recombinant Human Insulin Sales and Value (2012-2017)

9.1.1 Benelux Recombinant Human Insulin Sales and Growth Rate (2012-2017)

9.1.2 Benelux Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Recombinant Human Insulin Sales Price Trend (2012-2017)

9.2 Benelux Recombinant Human Insulin Sales and Market Share by Manufacturers

9.3 Benelux Recombinant Human Insulin Sales and Market Share by Type

9.4 Benelux Recombinant Human Insulin Sales and Market Share by Application



10 Europe Recombinant Human Insulin Manufacturers Analysis

10.1 Novo Nordisk

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Recombinant Human Insulin Product Type, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Eli Lilly

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Recombinant Human Insulin Product Type, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Bioton

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Recombinant Human Insulin Product Type, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Dongbao

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Recombinant Human Insulin Product Type, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 United Laboratories (TUL)

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Recombinant Human Insulin Product Type, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview



11 Recombinant Human Insulin Manufacturing Cost Analysis

11.1 Recombinant Human Insulin Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Recombinant Human Insulin



12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Recombinant Human Insulin Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015

12.4 Downstream Buyers



13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List



14 Europe Recombinant Human Insulin Market Forecast (2017-2022)

14.1 Germany Recombinant Human Insulin Sales Forecast (2017-2022)

14.2 France Recombinant Human Insulin Sales Forecast (2017-2022)

14.3 UK Recombinant Human Insulin Sales Forecast (2017-2022)

14.4 Russia Recombinant Human Insulin Sales Forecast (2017-2022)

14.5 Italy Recombinant Human Insulin Sales Forecast (2017-2022)

14.6 Spain Recombinant Human Insulin Sales Forecast (2017-2022)

14.7 Benelux Recombinant Human Insulin Sales Forecast (2017-2022)

14.8 Europe Recombinant Human Insulin Sales Forecast by Type (2017-2022)

14.9 Europe Recombinant Human Insulin Sales Forecast by Application (2017-2022)



15 Research Findings and Conclusion



16 Appendix

Methodology

Analyst Introduction

Data Source






List of Tables and Figures



Figure Picture of Recombinant Human Insulin

Table Classification of Recombinant Human Insulin

Figure Europe Sales Market Share of Recombinant Human Insulin by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Recombinant Human Insulin

Figure Europe Sales Market Share of Recombinant Human Insulin by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure France Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure UK Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure Russia Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure Italy Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure Spain Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure Benelux Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Figure Europe Recombinant Human Insulin Sales and Growth Rate (2012-2022)

Figure Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

Table Europe Recombinant Human Insulin Sales of Key Manufacturers (2015 and 2016)

Table Europe Recombinant Human Insulin Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Recombinant Human Insulin Sales Share by Manufacturers

Figure 2016 Recombinant Human Insulin Sales Share by Manufacturers

Table Europe Recombinant Human Insulin Revenue by Manufacturers (2015 and 2016)

Table Europe Recombinant Human Insulin Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Recombinant Human Insulin Revenue Share by Manufacturers

Table 2016 Europe Recombinant Human Insulin Revenue Share by Manufacturers

Table Europe Recombinant Human Insulin Sales and Market Share by Type (2012-2017)

Table Europe Recombinant Human Insulin Sales Share by Type (2012-2017)

Figure Sales Market Share of Recombinant Human Insulin by Type (2012-2017)

Figure Europe Recombinant Human Insulin Sales Growth Rate by Type (2012-2017)

Table Europe Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)

Table Europe Recombinant Human Insulin Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Recombinant Human Insulin by Type (2012-2017)

Figure Europe Recombinant Human Insulin Revenue Growth Rate by Type (2012-2017)

Table Europe Recombinant Human Insulin Sales and Market Share by Countries (2012-2017)

Table Europe Recombinant Human Insulin Sales Share by Countries (2012-2017)

Figure Sales Market Share of Recombinant Human Insulin by Countries (2012-2017)

Table Europe Recombinant Human Insulin Revenue and Market Share by Countries (2012-2017)

Table Europe Recombinant Human Insulin Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Recombinant Human Insulin by Countries (2012-2017)

Table Europe Recombinant Human Insulin Sales and Market Share by Application (2012-2017)

Table Europe Recombinant Human Insulin Sales Share by Application (2012-2017)

Figure Sales Market Share of Recombinant Human Insulin by Application (2012-2017)

Figure Germany Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure Germany Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure Germany Recombinant Human Insulin Sales Price Trend (2012-2017)

Table Germany Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table Germany Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table Germany Recombinant Human Insulin Sales by Type (2015 and 2016)

Table Germany Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table Germany Recombinant Human Insulin Sales by Application (2015 and 2016)

Table Germany Recombinant Human Insulin Market Share by Application (2015 and 2016)

Figure France Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure France Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure France Recombinant Human Insulin Sales Price Trend (2012-2017)

Table France Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table France Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table France Recombinant Human Insulin Sales by Type (2015 and 2016)

Table France Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table France Recombinant Human Insulin Sales by Application (2015 and 2016)

Table France Recombinant Human Insulin Market Share by Application (2015 and 2016)

Figure UK Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure UK Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure UK Recombinant Human Insulin Sales Price Trend (2012-2017)

Table UK Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table UK Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table UK Recombinant Human Insulin Sales by Type (2015 and 2016)

Table UK Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table UK Recombinant Human Insulin Sales by Application (2015 and 2016)

Table UK Recombinant Human Insulin Market Share by Application (2015 and 2016)

Figure Russia Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure Russia Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure Russia Recombinant Human Insulin Sales Price Trend (2012-2017)

Table Russia Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table Russia Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table Russia Recombinant Human Insulin Sales by Type (2015 and 2016)

Table Russia Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table Russia Recombinant Human Insulin Sales by Application (2015 and 2016)

Table Russia Recombinant Human Insulin Market Share by Application (2015 and 2016)

Figure Italy Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure Italy Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure Italy Recombinant Human Insulin Sales Price Trend (2012-2017)

Table Italy Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table Italy Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table Italy Recombinant Human Insulin Sales by Type (2015 and 2016)

Table Italy Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table Italy Recombinant Human Insulin Sales by Application (2015 and 2016)

Table Italy Recombinant Human Insulin Market Share by Application (2015 and 2016)

Figure Spain Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure Spain Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure Spain Recombinant Human Insulin Sales Price Trend (2012-2017)

Table Spain Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table Spain Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table Spain Recombinant Human Insulin Sales by Type (2015 and 2016)

Table Spain Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table Spain Recombinant Human Insulin Sales by Application (2015 and 2016)

Table Spain Recombinant Human Insulin Market Share by Application (2015 and 2016)

Figure Benelux Recombinant Human Insulin Sales and Growth Rate (2012-2017)

Figure Benelux Recombinant Human Insulin Revenue and Growth Rate (2012-2017)

Figure Benelux Recombinant Human Insulin Sales Price Trend (2012-2017)

Table Benelux Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)

Table Benelux Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)

Table Benelux Recombinant Human Insulin Sales by Type (2015 and 2016)

Table Benelux Recombinant Human Insulin Market Share by Type (2015 and 2016)

Table Benelux Recombinant Human Insulin Sales by Application (2015 and 2016)

Table Benelux Recombinant Human Insulin Market Share by Application (2015 and 2016)

Table Recombinant Human Insulin Basic Information List

Table Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novo Nordisk Recombinant Human Insulin Sales Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lilly Recombinant Human Insulin Sales Market Share (2012-2017)

Table Bioton Basic Information List

Table Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bioton Recombinant Human Insulin Sales Market Share (2012-2017)

Table Dongbao Basic Information List

Table Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Dongbao Recombinant Human Insulin Sales Market Share (2012-2017)

Table United Laboratories (TUL) Basic Information List

Table United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)

Table United Laboratories (TUL) Recombinant Human Insulin Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Human Insulin

Figure Manufacturing Process Analysis of Recombinant Human Insulin

Figure Recombinant Human Insulin Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015

Table Major Buyers of Recombinant Human Insulin

Table Distributors/Traders List

Figure Germany Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure Germany Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Figure France Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure France Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Figure UK Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure UK Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure Russia Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure Italy Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure Spain Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)

Table Europe Recombinant Human Insulin Sales Forecast by Type (2017-2022)

Table Europe Recombinant Human Insulin Sales Forecast by Application (2017-2022)



Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com